Clopidogrel non-responsiveness and risk of cardiovascular morbidity: An updated meta-analysis

Francesco Sofi, Rossella Marcucci, Anna Maria Gori, Betti Giusti, Rosanna Abbate, Gian Franco Gensini

Research output: Contribution to journalArticle

166 Citations (Scopus)

Abstract

We performed this meta-analysis to update the clinical evidences on the relation between clopidogrel non-responsiveness and clinical outcomes in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention. An electronic literature search through MEDLINE, EMBASE, Web of Science, and the Cochrane Library and bibliographies of retrieved articles up to January, 2009 was conducted. Studies were included if they had a cohort prospective design, if they analysed clopidogrel responsiveness in CAD patients in relation to death and/or occurrence of adverse coronary events during followup, and if they reported an adequate statistical analysis. Fourteen studies, totalling 4,564 CAD patients followed for a time ranging from 14 days to one year, were included. The cumulative analysis reported that residual platelet reactivity despite clopidogrel treatment was significantly associated with an increased risk of death and/or thrombotic recurrences (odds ratio [OR] 5.67, 95% confidence interval [CI] 2.97 to 10.84; p

Original languageEnglish
Pages (from-to)841-848
Number of pages8
JournalThrombosis and Haemostasis
Volume103
Issue number4
DOIs
Publication statusPublished - Apr 2010

Fingerprint

clopidogrel
Meta-Analysis
Coronary Artery Disease
Morbidity
Library Science
Bibliography
Percutaneous Coronary Intervention
MEDLINE
Blood Platelets
Odds Ratio
Confidence Intervals
Recurrence

Keywords

  • Antiplatelet therapy
  • Clinical recurrences
  • Clopidogrel
  • Meta-analysis

ASJC Scopus subject areas

  • Hematology

Cite this

Clopidogrel non-responsiveness and risk of cardiovascular morbidity : An updated meta-analysis. / Sofi, Francesco; Marcucci, Rossella; Gori, Anna Maria; Giusti, Betti; Abbate, Rosanna; Gensini, Gian Franco.

In: Thrombosis and Haemostasis, Vol. 103, No. 4, 04.2010, p. 841-848.

Research output: Contribution to journalArticle

Sofi, Francesco ; Marcucci, Rossella ; Gori, Anna Maria ; Giusti, Betti ; Abbate, Rosanna ; Gensini, Gian Franco. / Clopidogrel non-responsiveness and risk of cardiovascular morbidity : An updated meta-analysis. In: Thrombosis and Haemostasis. 2010 ; Vol. 103, No. 4. pp. 841-848.
@article{f960ad488f344494b60a366a859197dc,
title = "Clopidogrel non-responsiveness and risk of cardiovascular morbidity: An updated meta-analysis",
abstract = "We performed this meta-analysis to update the clinical evidences on the relation between clopidogrel non-responsiveness and clinical outcomes in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention. An electronic literature search through MEDLINE, EMBASE, Web of Science, and the Cochrane Library and bibliographies of retrieved articles up to January, 2009 was conducted. Studies were included if they had a cohort prospective design, if they analysed clopidogrel responsiveness in CAD patients in relation to death and/or occurrence of adverse coronary events during followup, and if they reported an adequate statistical analysis. Fourteen studies, totalling 4,564 CAD patients followed for a time ranging from 14 days to one year, were included. The cumulative analysis reported that residual platelet reactivity despite clopidogrel treatment was significantly associated with an increased risk of death and/or thrombotic recurrences (odds ratio [OR] 5.67, 95{\%} confidence interval [CI] 2.97 to 10.84; p",
keywords = "Antiplatelet therapy, Clinical recurrences, Clopidogrel, Meta-analysis",
author = "Francesco Sofi and Rossella Marcucci and Gori, {Anna Maria} and Betti Giusti and Rosanna Abbate and Gensini, {Gian Franco}",
year = "2010",
month = "4",
doi = "10.1160/TH09-06-0418",
language = "English",
volume = "103",
pages = "841--848",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "4",

}

TY - JOUR

T1 - Clopidogrel non-responsiveness and risk of cardiovascular morbidity

T2 - An updated meta-analysis

AU - Sofi, Francesco

AU - Marcucci, Rossella

AU - Gori, Anna Maria

AU - Giusti, Betti

AU - Abbate, Rosanna

AU - Gensini, Gian Franco

PY - 2010/4

Y1 - 2010/4

N2 - We performed this meta-analysis to update the clinical evidences on the relation between clopidogrel non-responsiveness and clinical outcomes in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention. An electronic literature search through MEDLINE, EMBASE, Web of Science, and the Cochrane Library and bibliographies of retrieved articles up to January, 2009 was conducted. Studies were included if they had a cohort prospective design, if they analysed clopidogrel responsiveness in CAD patients in relation to death and/or occurrence of adverse coronary events during followup, and if they reported an adequate statistical analysis. Fourteen studies, totalling 4,564 CAD patients followed for a time ranging from 14 days to one year, were included. The cumulative analysis reported that residual platelet reactivity despite clopidogrel treatment was significantly associated with an increased risk of death and/or thrombotic recurrences (odds ratio [OR] 5.67, 95% confidence interval [CI] 2.97 to 10.84; p

AB - We performed this meta-analysis to update the clinical evidences on the relation between clopidogrel non-responsiveness and clinical outcomes in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention. An electronic literature search through MEDLINE, EMBASE, Web of Science, and the Cochrane Library and bibliographies of retrieved articles up to January, 2009 was conducted. Studies were included if they had a cohort prospective design, if they analysed clopidogrel responsiveness in CAD patients in relation to death and/or occurrence of adverse coronary events during followup, and if they reported an adequate statistical analysis. Fourteen studies, totalling 4,564 CAD patients followed for a time ranging from 14 days to one year, were included. The cumulative analysis reported that residual platelet reactivity despite clopidogrel treatment was significantly associated with an increased risk of death and/or thrombotic recurrences (odds ratio [OR] 5.67, 95% confidence interval [CI] 2.97 to 10.84; p

KW - Antiplatelet therapy

KW - Clinical recurrences

KW - Clopidogrel

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=77952075376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952075376&partnerID=8YFLogxK

U2 - 10.1160/TH09-06-0418

DO - 10.1160/TH09-06-0418

M3 - Article

C2 - 20135063

AN - SCOPUS:77952075376

VL - 103

SP - 841

EP - 848

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 4

ER -